Skip to content
10-Q

Quarterly Report

DUSA PHARMACEUTICALS INC

0000950123-11-097355

← back to feed
Filed
Nov 10, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 9, 2011 24.65M sh
Stockholders Equity Q3 2011 · Sep 30, 2011 $24.66M
Stockholders Equity Q3 2011 · Dec 31, 2010 $19.52M
Current Liabilities Q3 2011 · Sep 30, 2011 $4.7M
Current Liabilities Q3 2011 · Dec 31, 2010 $5.47M
Total Liabilities Q3 2011 · Sep 30, 2011 $7.47M
Total Liabilities Q3 2011 · Dec 31, 2010 $8.77M
Current Assets Q3 2011 · Sep 30, 2011 $30.37M
Current Assets Q3 2011 · Dec 31, 2010 $26.47M
Total Assets Q3 2011 · Sep 30, 2011 $32.13M
Total Assets Q3 2011 · Dec 31, 2010 $28.29M
Shares Diluted Q3 2011 · Sep 30, 2010 24.66M sh
Shares Diluted Q3 2011 · Sep 30, 2010 24.17M sh
Capex Q3 2011 · Sep 30, 2010 $128.9K
Operating Cash Flow Q3 2011 · Sep 30, 2010 $573.9K
Cash And Equivalents Q3 2011 · Sep 30, 2010 $6.18M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $7.61M
Eps Diluted Q3 2011 · Sep 30, 2010 $0.00
Eps Diluted Q3 2011 · Sep 30, 2010 −$0.01
Eps Basic Q3 2011 · Sep 30, 2010 $0.00
Eps Basic Q3 2011 · Sep 30, 2010 −$0.01
Sga Expense Q3 2011 · Sep 30, 2010 $2.21M
Sga Expense Q3 2011 · Sep 30, 2010 $6.92M
Rd Expense Q3 2011 · Sep 30, 2010 $1.28M
Rd Expense Q3 2011 · Sep 30, 2010 $3.64M
Net Income Q3 2011 · Sep 30, 2010 $32.82K
Net Income Q3 2011 · Sep 30, 2010 −$203.47K
Operating Income Q3 2011 · Sep 30, 2010 $102.32K
Operating Income Q3 2011 · Sep 30, 2010 $94.75K
Gross Profit Q3 2011 · Sep 30, 2010 $6.39M
Gross Profit Q3 2011 · Sep 30, 2010 $20.2M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $1.63M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $5.23M